CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Planned sale Director sold 23,033 shares at $7.18 ($165,306)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 4 Conversion See remarks acquired 4,606,596 shares (conversion)
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure · Other events
- 4 Planned sale Director sold 75,000 shares at $12.01 ($900,788)
Page 2 of 28 · 557 filings